Posts With Tag NASDAQ AXSM

Explore Axsome Therapeutics' 8-K report filed on Feb 18, 2025, detailing significant updates affecting stock AXSM on NASDAQ. Stay informed on crucial company events.

Discover crucial updates from Axsome Therapeutics, Inc. in their 8-K report filed on February 10, 2025. Key insights for investors and stakeholders.

Discover the key information from Axsome Therapeutics' 8-K filing on January 13, 2025. Learn about significant corporate changes and stock details essential for investors.